- $930.16m
- $919.50m
- $93.82m
- 75
- 64
- 49
- 66
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 46.9 | 36.4 | 60.9 | 126 | 93.8 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 2.86 | 3.06 | 3.05 | 3.29 | 3.56 |
Operating Profit | 44 | 33.3 | 57.9 | 123 | 90.3 |
Net Income Before Taxes | 44 | 33.3 | 57.9 | 123 | 90.3 |
Net Income After Taxes | 44 | 33.3 | 57.9 | 123 | 90.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 44 | 33.3 | 57.9 | 123 | 90.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 44 | 33.3 | 57.9 | 123 | 90.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.02 | 2.28 | 3.97 | 8.42 | 6.19 |
Dividends per Share |